When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

New drug development is a race against the clock as soon as the first patents are filed, and understanding the potential timings from first-in-human studies to regulatory approval is crucial for ...

When it comes to developing new drugs, one of the most time-consuming and complex pieces of the puzzle is the task of compiling all of the data collected throughout the clinical development process to ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabilities ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The pharmaceutical industry is at a critical turning point. Drug discovery has evolved rapidly, but clinical development remains slow, expensive, and inefficient. Clinical trials, especially ...

Health systems and their technology vendors can work together to modernize clinical process maps using artificial intelligence – transforming them from static reference documents into living guidance ...

There’s a lot of risk inherent in biotech investment, but a new report suggests that an increasingly safe bet is one of the hottest areas of drug development: cell and gene therapy. A new report from ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

WHITEHOUSE STATION, N.J. & BOSTON--(BUSINESS WIRE)-- Merck (NYSE:MRK) (known outside the United States and Canada as MSD) and PAREXEL International Corporation (NASDAQ: PRXL), a leading global ...